Contact Information
  • 800-826-HOPE (4673)
Anna Pawlowska, M.D.
  • Clinical Professor
  • Director, Pediatric Hematopoietic Stem Cell Transplantation (HCT) Program

Primary Specialties

Clinical Area / Sub-specialties

Departments/Division/Program

Languages Spoken
  • Polish

Professional Experience


  • 2013 - Present, Director, Pediatric Bone Marrow Transplantation (BMT) Program, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
  • 2000 - present, Clinical Associate Professor and Staff Physician, Department of Pediatrics, City of Hope, Duarte, CA
  • 2011, Acting Chair, Department of Pediatrics, City of Hope, Duarte, CA
  • 1999, Staff Physician, Pediatric Hematology/Oncology, Minneapolis Children's Hospital, Minneapolis, MN
  • 1995 - 1998, Fellow, Pediatric Hematology/Oncology/BMT, Dept. of Pediatrics, University of Minnesota, Minneapolis, MN
  • 1992 - 1995, Pediatric Resident, Dept. of Pediatrics, University of Colorado Health Sciences Center, The Children's Hospital, Denver, CO
  • 1991 - 1992, Immunofluorescence Laboratory, Dept. of Dermatology, University of Colorado Health Sciences Center, Denver, CO
  • 1986 - 1990, Resident, Dept. of Dermatology, University Medical School, Poznan, Poland
  • 1985 - 1986, Intern, University Medical Center, Poznan, Poland

Education

 
Education/Training
  • 1979 - 1985, K. Marcinkowski University School of Medicine, Poznan, Poland, M.D.
 

Honors/Awards

 
Awards
  • 1998, The Margaret K Hostetter Award for Research by a Fellow in Pediatric Subspecialty Training
  • 1985, Polish Society for Immunology Scientific Award

Honors
  • 1998, First Place Presentation, University of Minnesota Pediatric Fellows Research Conference
  • 1985, Frederic Schiller Gold Medal For Scientific Achievements, University of Jena, Germany
  • 1985, Karol Marcinkowski Medal for Academic Excellence University School of Medicine, Poznan, Poland
 

Publications


  • A Mackiewicz, T Pawlowski, A Pawlowska, K Wiktorowicz, SH Mackiewicz. Microheterogeneity forms of a-1-acid glycoprotein as indicator of rheumatoid arthritis activity. Clin Chim Acta 1987, 163, 185-190
  • AB Pawlowska, SM Davies, PJ Orchard, JE Wagner, NKC Ramsay. Unrelated donor bone marrow transplantation for acute leukemia in patients with Down syndrome. Bone Marrow Transplantation 1996, 18, 453-455
  • AB Pawlowska, BR Blazar, E Angelucci, D Baronciani, XO Shu, B Bostrom. Relationship of plasma pharmacokinetics of high dose oral busulfan to the outcome of allogeneic bone marrow transplantation in children with thalassemia. Bone Marrow Transplantation 1997, 20, 915-920
  • AB Pawlowska, S Hashino, H McKenna, BJ Weigel, PA Taylor, BR Blazar. In vitro tumor-pulsed or in vivo Flt3 ligand-generated dendritic cells provide protection against acute myelogenous leukemia in nontransplanted or syngeneic bone marrow-transplanted mice. Blood 2001, 97, 1474-1482
  • AB Pawlowska. Detection of minimal residual disease in childhood acute lymphoblastic leukemia: technology and clinical applications. Wspolczesna Onkologia (Current Oncology) 2005, 9, 178-182.
  • Rosenthal J, Bolotin E, Shakhnovits M, Pawlowska A, Falk P, Qian D, Oliver C, Sato J, Miser J, Forman S. High-dose therapy with hematopoietic stem cell rescue in patients with poor prognosis Ewing family tumors. Bone Marrow Transplant. 42(5):311-8, 2008.
  • Joseph Rosenthal MD,  Anna B Pawlowska MD. High dose chemotherapy and stem cell rescue in high-risk Ewing family of tumors (EFT). Expert Rev Anticancer Ther. 2011 Feb;11(2):251-62
  • Rosenthal J, Woolfrey AE, Pawlowska A, Thomas SH, Appelbaum F, Forman S. Hematopoietic cell transplantation with autologous cord blood in patients with severe aplastic anemia: An opportunity to revisit the controversy regarding cord blood banking for private use. Pediatr Blood Cancer. 2011 Mar 2. doi: 10.1002/pbc.22970. [Epub ahead of print]
  • Rosenthal J, Pawlowska A, Bolotin E, Cervantes C, Maroongroge S, Thomas SH, Forman SJ. Transplant-associated thrombotic microangiopathy in pediatric patients treated with sirolimus and tacrolimus. Pediatr Blood Cancer. 2011 Jul 15;57(1):142-6
  • Young S. Kim MD, Huiqing Wu MD, Anna B. Pawlowska MD, Marnelli A. Bautista-Quach MD, Qin Huang MD PhD, Karl Gaal MD, Karen Chang MD Pediatric Mast Cell Sarcoma of Temporal Bone with Novel L799F (2395 C>T) KIY Mutation, Mimicking Histiocytic NeoplasmAm J Surg Pathol _ Volume 37, Number 3, March 2013
  • American Society of Hematology (ASH) Dec. 1996, Orlando AB Pawlowska, SM Davies, PJ Orchard, JE Wagner, NKC Ramsay. Unrelated donor bone marrow transplantation for acute leukemia in patients with Down syndrome.
  • FASEB/American Association of Immunologists, April 98, San Francisco AB.Pawlowska, S.Hashino, PA Taylor, DA Vallera, BR.Blazar. Both the primary and memory cell effector response against murine acute myeloid leukemia (AML) is completely eliminated by effective blockage of B7-CD28 interaction in subcutaneous (SQ) immunization model
  • American Society of Hematology (ASH) Dec. 1998, Miami Beach Oral presentation: AB Pawlowska, S.Hashino, H McKenna, PA Taylor and BR Blazar. In vitro tumor pulsed or in vivo FLT3 ligand induced dendritic cells provide protection against acute myelogenous leukemia in naive or syngeneic bone marrow transplanted mice
  • 4.S.Hashino, AB.Pawlowska, PA Taylor, BR.Blazar Intact B7/CD28:CTLA4 costumulatory pathway is critical for primary and memory cell effector response against murine acute myeloid leukemia (AML) in subcutaneous (sq) immunization model.
  • BMT Tandem Meeting (ASBMT/CIBMTR), Feb 2009, Tampa, Florida
  • Anna B Pawlowska MD, Ellen Bolotin MD, Kimberly Mai-ton, David Senitzer PhD, Andy Dagis, Shirong Wang MD, Monica Zlotnicki, Stephen Forman MD, Joseph Rosenthal MD. Outcomes of Hematopoietic Stem Cell Transplantation (HCT) from Umbilical Cord Blood (UCB) Units in Patients with Malignant and Non-malignant Disorders
  • Anna B Pawlowska MD, Jerry Cheng MD, Tracey Stiller MS, Joycelynne Palmer PhD, Nael Hafeez, Joseph Rosenthal MD. Outcome of Second Allogeneic Stem Cell Transplantation (SCT) in Pediatric Patients with Graft Failure or Recurrent Leukemia.
  • BMT Tandem Meeting (ASBMT/CIBMTR), Feb 2012, San Diego, CA
  • Anna B Pawlowska MD, Julie Wolfson MD, Jerry Cheng MD, April Sorrell MD, Judith Sato MD, Clarke Anderson MD, Debbie Hitt RN, Mary Suarez CRA, Stephen J Forman MD, Joseph Rosenthal MD. High dose chemotherapy (HDT) with busulfan, melphalan  and topotecan followed by autologous hematopoietic stem cell transplantation (ASCT) in pediatric patients (pts) with high risk solid tumors.
     

Locations


  • City of Hope | Main Campus (Duarte)
    1500 East Duarte Road
    Duarte, CA 91010